Austria FWF · Forthcoming · Consortium required

European Partnership ERDERA

Official call page ↗

In brief, in English

This call funds transnational collaborative research projects focused on recently identified and scientifically underserved rare diseases. Researchers working at universities, non-academic research institutions, or research departments in related sectors can apply as part of an international consortium.

Written by a model from the publisher's text. The official page is the authority. How data is produced

Research on rare diseases Submissions: Dec. 1, 2026 to Feb. 1, 2027 The European Rare Diseases Research Alliance (ERDERA) was established to further help in coordinating the research efforts of European, associated and non-European countries in the field of rare diseases and to implement the objectives of the International Rare Disease Research Consortium (IRDiRC). These actions are a follow-up to the five Joint Transnational Calls for rare diseases research projects launched previously by the European Joint Program on Rare Diseases (EJP RD) since 2019. The third call, “Catalysing Collaborative Research for Recently Identified Rare Diseases,” is open until February 1, 2027, for pre-proposals and June 24, 2027, for full proposals. Target group The funding program is aimed at researchers working in the field of rare diseases at universities, non-academic research institutions, and research departments in related sectors. Funding goals ERDERA has the ambition to improve the health and well-being of the 30 million individuals living with rare diseases in Europe, both by making Europe a world leader in RD research and innovation and by delivering concrete health benefits to rare disease patients through better prevention, diagnosis, and treatment. Funding period and funding amount The following applies for FWF-funded principal investigators: The funding period is at least 24 months and up to 36 months; the minimum funding amount is €200,000, and the maximum funding amount is €450,000. Requirements The requirements and specifications for the FWF programs Principal Investigator Projects or Clinical Research apply. Information on the current call “Catalysing Collaborative Research for Recently Identified Rare Diseases” The goal of this call is to stimulate research interest and catalyze new collaborative initiatives centered on recently identified RDs that remain scientifically underserved. By advancing the understanding of natural history and disease pathomechanisms, and by fostering the development of relevant disease models, the overarching aim is to generate the foundational knowledge required to accelerate future therapeutic development. For further information on thematic requirements and restrictions of this call, please see the ERDERA website. Each proposal must involve a minimum of three and a maximum of six partners from at least three different participating partner countries. A joint proposal must be submitted by the project coordinator to the central Call Secretariat. The number of partners may be increased to eight if early-stage researchers or partners from underrepresented countries are included. In addition, it is recommended that a patient organization be represented in each consortium (patient organizations are not counted toward the total number of partners). The researchers are funded by their respective national/regional funding organizations. The current list of participating countries can be found on the ERDERA website. Approval Decided by the Scientific Board based on a recommendation of the Call Secretariat. Application information Applications must be submitted to both the Call Secretariat and the FWF. This applies to both the pre-proposal and the full proposal. Submission to the Call Secretariat Please see the ERDERA website for the link to the Call Secretariat’s application system. Application and review are carried out in a two-stage procedure. Submission of pre-proposals: December 1, 2026 to February 1, 2027 (2:00 pm CET) Deadline for full proposals: June 24, 2027 (2:00 pm CEST) Funding decision: expected in December 2027 Submission to the FWF In addition to the application to the Call Secretariat, administrative and financial data as well as the academic abstracts for the proposal must be submitted to the FWF on elane (in compliance with the FWF application guidelines for Principal Investigator Projects or Clinical Research): In the pre-proposal phase, applications must be submitted under the

Change history

First seen 17 Nov 2026, last checked 22 Nov 2026. 1 recorded version.

  • 17 Nov 2026 · b08f75841964

Report a problem with this record · How data is produced